胜牌 VVV 深 沪
已收盘 08-21 16:00:00 美东时间
33.96
+0.150
+0.44%
华盛通- 最 高34.11
- 今 开33.98
- 成交量 144.05万股
- 最 低 33.51
- 昨 收 33.81
- 总市值 43.33亿
- 52周最高 41.33
- 市盈率 静 20.73
- 换手率 1.13%
- 52周最低 28.50
- 委 比 61.94%
- 总股本 1.28亿
- 历史最高 48.265
- 量 比 0.76
- 振 幅 1.77%
- 历史最低 7.709
- 每 手 1
- 风险率 3.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Benchmark Initiates Coverage On Valvoline with Buy Rating, Announces Price Target of $48
Benchmark analyst Michael Albanese initiates coverage on Valvoline (NYSE:VVV) with a Buy rating and announces Price Target of $48.
08-20 23:32
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
RBC Capital Maintains Outperform on Valvoline, Lowers Price Target to $46
RBC Capital analyst Steven Shemesh maintains Valvoline (NYSE:VVV) with a Outperform and lowers the price target from $47 to $46.
08-07 01:58
财报速睇 | 胜牌2026财年Q2营收5.45亿美元，同比增长24.1%；归母净利润0.65亿美元，同比增长14.2%
华盛资讯8月6日讯，胜牌公布2026财年Q2业绩，公司Q2营收5.45亿美元，同比增长24.1%，归母净利润0.65亿美元，同比增长14.2%。
08-06 07:53
Franchise Equity Partners Marks 50-Location Milestone with Velocity Auto Care Expansion
Achievement reflects continued expansion following 2024 acquisition, with 18 additional service centers planned through 2027 NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Franchise Equity Partners ...
08-06 03:43
财报速睇 | 胜牌2026财年Q2营收5.45亿美元，同比增长24.1%；归母净利润0.65亿美元，同比增长14.2%
华盛资讯8月5日讯，胜牌公布2026财年Q2业绩，公司Q2营收5.45亿美元，同比增长24.1%，归母净利润0.65亿美元，同比增长14.2%。
08-05 19:57
Valvoline Q3 Adj. EPS $0.57 Beats $0.50 Estimate, Sales $544.600M Beat $542.342M Estimate
Valvoline (NYSE:VVV) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.50 by 14 percent. This is a 21.28 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $544.600 million which beat ...
08-05 19:03
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
Stephens & Co. Maintains Overweight on Valvoline, Raises Price Target to $48
Stephens & Co. analyst Thomas Wendler maintains Valvoline (NYSE:VVV) with a Overweight and raises the price target from $44 to $48.
07-28 20:32
